[1]Zhang X, Bi X. Poststroke cognitive impairment: a review focusing on molecular biomarkers[J]. J Mol Neurosci, 2020, 70(8): 1244-1254.
[2]Margolis KG, Cryan JF, Mayer EA. The microbiotagutbrain axis: from motility to mood[J]. Gastroenterology, 2021, 160(5): 1486-1501.
[3]Ling Y, Gong T, Zhang J, et al. Gut microbiome signatures are biomarkers for cognitive impairment in patients with ischemic stroke[J]. Front Aging Neurosci, 2020, 12: 511562.
[4]Ayling RM, Kok K. Fecal calprotectin[J]. Adv Clin Chem, 2018, 87: 161-190.
[5]汪凯, 董强, 郁金泰, 等. 卒中后认知障碍管理专家共识2021[J]. 中国卒中杂志, 2021, 16(4): 376-389.
[6]Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiotabrain axis in behaviour and brain disorders[J]. Nat Rev Microbiol, 2021, 19(4): 241-255.
[7]Mulak A, Koszewicz M, PanekJeziorna M, et al. Fecal calprotectin as a marker of the gut immune system activation is elevated in Parkinson′s disease[J]. Front Neurosci, 2019, 13: 992.
[8]Park SY, Lee SP, Kim WJ. Fecal calprotectin is increased in stroke[J]. J Clin Med, 2021, 11(1): 159.
[9]宋欣娜, 张铭思, 尹恝. 脑卒中后认知功能障碍与肠道菌群紊乱研究进展[J]. 中国现代神经疾病杂志, 2021, 21(1): 34-40.
[10]Liu Y, Kong C, Gong L, et al. The association of poststroke cognitive impairment and gut microbiota and its corresponding metabolites[J]. J Alzheimers Dis, 2020, 73(4): 1455-1466.
[11]冯丹, 余茜, 李亚梅, 等. 卒中后认知障碍患者康复干预前后粪便短链脂肪酸变化的研究[J]. 实用医院临床杂志, 2022, 19(2): 147-150.
[12]Wright MJ, Sullivan RR, GaffneyStomberg E, et al. Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial[J]. J Bone Miner Res, 2010, 25(10): 2205-2211.
[13]Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gutbrain axis[J]. Science, 2021, 374(6571): 1087-1092.
|